Search research articles
Contact Us
Filters
Showing results (101-110 of 293) with videos related to
Page
of 30
Sort By:
Cell Cycle (Georgetown, Tex.)
|
January 19, 2010
Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression
Giancarlo Castellano, Elena Torrisi, Giovanni Ligresti, et al.
BMC Bioinformatics
|
February 6, 2019
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation
Saverio Candido, Giuseppe Alessandro Parasiliti Palumbo, Marzio Pennisi, et al.
BMC Cancer
|
June 18, 2017
The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study
Martina Taborelli, Maurizio Montella, Massimo Libra, et al.
Plos One
|
July 21, 2015
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis
Grazia Malaponte, Salvatore S Signorelli, Valentina Bevelacqua, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 6, 2012
Comparative study of rapamycin and temsirolimus demonstrates superimposable anti-tumour potency on prostate cancer cells
Paolo Fagone, Marco Donia, Katia Mangano, et al.
International Journal of Molecular Medicine
|
March 15, 2024
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots
Giuseppe Gattuso, Alessandro Lavoro, Rosario Caltabiano, et al.
Plos One
|
March 26, 2016
Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
Francesco Pappalardo, Giulia Russo, Saverio Candido, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
August 2, 2016
Metabolic disorders and the risk of nasopharyngeal carcinoma: a case-control study in Italy
Antonella Zucchetto, Martina Taborelli, Cristina Bosetti, et al.
Frontiers in Pharmacology
|
August 30, 2018
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With <i>BRAF</i><sup>V600E</sup> Mutation Detected in Circulating-Free DNA
Rossella Salemi, Luca Falzone, Gabriele Madonna, et al.
Molecular Medicine Reports
|
April 7, 2011
Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review)
Marco Aiello, Nadia Vella, Calogero Cannavò, et al.
Page
of 30
Search research articles
Search
Showing results (101-110 of 293) with videos related to
Sort By:
Page
of 30
Cell Cycle (Georgetown, Tex.)
|
January 19, 2010
Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression
Giancarlo Castellano, Elena Torrisi, Giovanni Ligresti, et al.
BMC Bioinformatics
|
February 6, 2019
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation
Saverio Candido, Giuseppe Alessandro Parasiliti Palumbo, Marzio Pennisi, et al.
BMC Cancer
|
June 18, 2017
The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study
Martina Taborelli, Maurizio Montella, Massimo Libra, et al.
Plos One
|
July 21, 2015
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis
Grazia Malaponte, Salvatore S Signorelli, Valentina Bevelacqua, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 6, 2012
Comparative study of rapamycin and temsirolimus demonstrates superimposable anti-tumour potency on prostate cancer cells
Paolo Fagone, Marco Donia, Katia Mangano, et al.
International Journal of Molecular Medicine
|
March 15, 2024
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots
Giuseppe Gattuso, Alessandro Lavoro, Rosario Caltabiano, et al.
Plos One
|
March 26, 2016
Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
Francesco Pappalardo, Giulia Russo, Saverio Candido, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
August 2, 2016
Metabolic disorders and the risk of nasopharyngeal carcinoma: a case-control study in Italy
Antonella Zucchetto, Martina Taborelli, Cristina Bosetti, et al.
Frontiers in Pharmacology
|
August 30, 2018
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With <i>BRAF</i><sup>V600E</sup> Mutation Detected in Circulating-Free DNA
Rossella Salemi, Luca Falzone, Gabriele Madonna, et al.
Molecular Medicine Reports
|
April 7, 2011
Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review)
Marco Aiello, Nadia Vella, Calogero Cannavò, et al.
Page
of 30